Patents by Inventor Kenneth O'Byrne

Kenneth O'Byrne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid oligomers and uses therefor
    Patent number: 11911410
    Abstract: Disclosed are nucleic acid oligomer compounds and to their use in compositions and methods for inhibiting proliferation, survival or viability of cancer cells including prostate, lung, pancreatic, breast, cervical and bone cancer cells.
    Type: Grant
    Filed: November 7, 2022
    Date of Patent: February 27, 2024
    Assignee: Repluca PTY LTD
    Inventors: Derek Richard, Kenneth O'Byrne, Laura Croft, Sam Beard
  • DETERMINING CANCER RESPONSIVENESS TO TREATMENT
    Publication number: 20230323466
    Abstract: The present disclosure relates to cancer and more particularly, methods of treating and/or determining the responsiveness to treatment and/or prognosis of cancers, such as lung cancer and breast cancer.
    Type: Application
    Filed: July 15, 2021
    Publication date: October 12, 2023
    Inventors: Mark ADAMS, Derek RICHARD, Kenneth O'BYRNE
  • NUCLEIC ACID OLIGOMERS AND USES THEREFOR
    Publication number: 20230256000
    Abstract: Disclosed are nucleic acid oligomer compounds and to their use in compositions and methods for inhibiting proliferation, survival or viability of cancer cells including prostate, lung, pancreatic, breast, cervical and bone cancer cells.
    Type: Application
    Filed: November 7, 2022
    Publication date: August 17, 2023
    Inventors: Derek Richard, Kenneth O'Byrne, Laura Croft, Sam Beard
  • Nucleic acid oligomers and uses therefor
    Patent number: 11534451
    Abstract: Disclosed are nucleic acid oligomer compounds and to their use in compositions and methods for inhibiting proliferation, survival or viability of cancer cells including prostate, lung, pancreatic, breast, cervical and bone cancer cells.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: December 27, 2022
    Assignee: REPLUCA PTY LTD
    Inventors: Derek Richard, Kenneth O'Byrne, Laura Croft, Sam Beard
  • NUCLEIC ACID OLIGOMERS AND USES THEREFOR
    Publication number: 20200230168
    Abstract: Disclosed are nucleic acid oligomer compounds and to their use in compositions and methods for inhibiting proliferation, survival or viability of cancer cells including prostate, lung, pancreatic, breast, cervical and bone cancer cells.
    Type: Application
    Filed: December 23, 2016
    Publication date: July 23, 2020
    Inventors: Derek Richard, Kenneth O'Byrne, Laura Croft, Sam Beard